ArticleBioengineering (Basel, Switzerland)2026
Non-Invasive Voice-Based Early Detection of Parkinson's Disease via Spectral Feature Analysis and Machine Learning Techniques.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParkinson's disease (PD) is a chronic, slowly progressive, and irreversible neuropathological disorder characterized by the progressive degeneration of specific neurons responsible for producing neurotransmitters essential for motor control. Although PD primarily affects motor function, various non-motor symptoms commonly emerge during the prodromal phase. These include autonomic dysfunction, cognitive and neurobehavioral disorders, and sensory and sleep abnormalities. Notably, speech and voice alterations, particularly hypokinetic dysarthria, are frequent manifestations. This research presents a methodology to distinguish between individuals with PD and healthy controls using voice signals through speech recognition and machine learning (ML) techniques. A dataset comprising 81 voice samples (41 healthy controls and 40 PD patients) was utilized to extract two types of cepstral features: Mel-frequency cepstral coefficients (MFCCs) and subband-based cepstral coefficients (SBCs). These extracted features were used to train and evaluate three ML algorithms: Random Forest (RF), K-Nearest Neighbors (KNN), and Support Vector Machines (SVM).
resultsAmong the algorithms evaluated, the SVM-SBC model exhibited the highest performance, achieving an accuracy of 79%, a sensitivity of 75.5%, and an Area Under the ROC Curve (AUC-ROC) of 84%.
conclusionsThis study highlights the potential of integrating cepstral features with machine learning algorithms to develop reliable, non-invasive tools for the early detection of PD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.